🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the efficacy and safety of two different...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-10
Trial ID
NCT01217944
Treatments Being Tested
This was a Phase III, multicenter, randomized, double-masked, sham injectio...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00485836
Treatments Being Tested
This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalat...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-01
Trial ID
NCT01397409
Treatments Being Tested
The objectives of this study are to evaluate the safety and efficacy of int...
Status
Terminated
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01944839
Treatments Being Tested
The purpose of this study is to determine the effect of ranibizumab for the...
Status
Terminated
Location
Seoul National University Bundang Hospital
Start Date
2013-01
Trial ID
NCT01795209
Treatments Being Tested
To evaluate the efficacy and safety of 0.5 mg Ranibizumab intravitreal inje...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-10
Trial ID
NCT01846299
Treatments Being Tested
The purpose of this study is to investigate the change in macular edema and...
Status
Completed
Location
Dept. of Ophthalmology, Medical University of Vienna
Start Date
2007-10
Trial ID
NCT00682539
Treatments Being Tested
The study will evaluate the safety and efficacy of the intravitreal implant...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-01
Trial ID
NCT00511706
Treatments Being Tested
Provided efficacy and safety data on intravitreal injections of ranibizumab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-11-12
Trial ID
NCT01976338
Treatments Being Tested
This is a phase III, multicenter, randomized, double masked, sham injection...
Status
Completed
Location
Trial Information Support Line
Start Date
2004-08
Trial ID
NCT00090623
Treatments Being Tested